Mapping tumor markers

BioGraph 55 is creating tumor maps to identify biomarkers and novel targets

BioGraph 55 Inc. is mapping immune cells in the tumor microenvironment to identify cell-to-cell interaction patterns that can help match patients to existing therapies and identify novel therapeutic targets. The newco is developing a pipeline with an initial focus on cancer patients who express PD-1 or PD-L1 but don’t respond to PD-1 or PD-L1 inhibitors.

“The problem that we saw in the clinic was that we were

Read the full 679 word article

User Sign In